• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Investing
  3. / Stocks

Watching Price Action, Pfizer Selloff, Trading Thoughts

Taking a chunk of Pfizer during this selloff, while Amazon has raised $10 billion in mixed-maturity debt and all eyes are on the government's response to civil unrest in the U.S.
By STEPHEN GUILFOYLE
Jun 02, 2020 | 07:22 AM EDT
Stocks quotes in this article: DKS, DCI, CRWD, ZM, AMZN, COST, PFE

Appearances

By all appearances, equity markets continue to move higher. Treasury securities remain stable. The U.S. dollar has weakened a little, but is not weak. Oil trades higher than it did last week. All this while every night, peaceful protests give way to violence. All this while the geopolitical condition between the U.S. and China worsens. All this as the nation struggles to reopen an economy shuttered by a public health crisis.

Why wouldn't equities continue their march higher. After all, money supply has been flooded with no alternative choices as to where some of this dough might land. Liquidity concerns, at least to the immediate front, have been taken care of. Cash flow, the life blood of solvency, can be replaced by debt.

For how long? This I don't know. We do know that it just was not safe to reopen the economy all at once, in some uncontrolled way. We know that many businesses in many cities will now either have to delay further any reopening, or not reopen at all in the wake of current events. We also suspect that the events of the past week could end up exacerbating the spread of the coronavirus that many had hoped might take a seasonal break over the warmer months of summer.

Now, the president threatens to use the military. Not just the National Guard -- a force that bears a dual function as both state militia and as a reserve component of the U.S. Army -- but Regulars, to control what has become out of control. A sad day for a nation already saddened. This is a development no one ever wants to see. No one.

"Maybe, it's not too late, to learn how to love, and forget how to hate."

--Ozzy Osbourne, 1981

Monday

In this column on Monday morning, I tried to illustrate a picture in your mind of equity markets walking on eggshells. This was because, for all of the reasons mentioned above, I felt that at some point algorithms that control the point of sale would turn on the marketplace at elevated valuations, with so much positivity priced in and not so much of the negative factored. Even after what on the surface was a solid day for the market, and even as equity index futures trade considerably higher overnight, I still think I see the fragility.

Sure, the broader large-cap indices all closed to the upside on Monday. That said, the "stay at home" economy stocks resumed their places at the top. Sort of. Internet stocks did well. Information Technology? Health Care? Not so much. The truth is that safety was sought in more defensive-type sectors, such as Utilities and REITs, though I don't know how defensive that group might be going forward at this juncture.

Trading volume trailed off badly on Monday. Overall breadth, in terms of winners versus losers as well as advancing volume versus declining volume, was overwhelmingly positive. Yet, at the headline level, trading volume was so light at New York's two primary exchanges as to nearly disqualify the day's results from my analysis.

With one huge exception. Price still matters. If you bought them or you sold them on Monday, the trade still counts. The uptrend, as I have mentioned over and over, remains this market's driving force, and it will until it does not. You can't change that. I can't change that. You and I, if we are smart enough, or agile enough, can benefit from trend. Whether we trust it or not.

Just Take A Look

Once again, the CBOE Options Index Put/Call ratio lands closer to the higher end of its recent range...

Readers might think that traders are indeed hedging their bets just a bit, and might certainly be a bit less confident than they were in mid-May. That said, you need to see this...

As far as the CBOE Options Equity Put/Call Ratio is concerned, investors are purchasing less downside protection for individual stocks than at any point since February. Crazy? Contrary? We will find out.

Got Your Attention?

Probably not. On Monday, the Atlanta Fed added data from the ISM Manufacturing Index for May, as well as April Construction Spending to its closely followed GDPNow model. The result was one of pure ugliness. The model, which is not considered a projection, but more of a real-time snapshot of annualized quarterly economic growth, reduced current values for Q2 real personal consumption expenditures and Q2 real gross private domestic investment growth.

The result is that the Atlanta Fed's GDPNow model for the second quarter is now showing economic growth for the current period of -52.8%. It won't be just horrific economic performance at the headline level, but also the fact that state and local governments are now being forced to respond to social unrest in the streets, exacerbating already broken local budgets. Add to this expectations that any economic recovery now takes longer -- and the fact that, for the beefed-up jobless benefits that so many are currently reliant upon, there will have to be an agreement at the legislative level to pass across both houses in a next fiscal support package sometime prior to the annual August recess period for congress.

Trading Notes

--I did notice the mixed shelf registration on Monday. Didn't take long. Amazon (AMZN) was able to raise $10B in corporate debt across three, seven, ten, thirty and forty-year maturities. Borrowing costs were minimal. Just 0.4% for the three-year paper. Coupons of just 1.2% and 1.5% for the seven-year and ten-year notes, respectively. Those were record-low costs for corporate paper of those two maturities by the way, beating a record already set in 2020 by Costco (COST) .

Amazon plans to use the funds raised for general corporate purposes. Readers will recall that though revenue has surged for the firm's e-commerce business this year, making that business safe for both employees and customers has been, and is expected to continue to be, expensive, perhaps putting to use the firm's entire expectation for what would have been operating profit over the next year or so. I maintain a long position in this name with a "loose" $2625 target price.

--Pfizer (PFE) sold off hard on Monday after reporting disappointing results from tests involving a regimen of the firm's "Ibrance" and standard endocrine therapy for patents suffering from Stage 2-3 breast cancer. Ibrance accounts for more than half of Pfizer's total oncology sales. There is no way to paint this as anything other than a setback.

In response, I doubled my long position in this name on Monday from 1/8 of a full position to 1/4. Why would I do such a thing? First, I am in the red on this one, so there is some self defense involved. Secondly, among large pharmaceutical firms, I believe Pfizer to be possibly ahead of the pack in producing a messenger-RNA-based vaccine for Covid-19. Ahead of the pack in terms of time and ability to mass produce. I have no idea of such key concerns as safety and efficacy.

--Zoom Video (ZM) reports this evening. The Street is looking for earnings growth of more than 200% on revenue of almost 70%, but the range of expectations across the 27 analysts that cover the stock is so wide, you could probably drive a truck through them using night vision.

I went out short this name on Monday night at an even $205 ( I only sold the initial tranche.). That looked okay as the bell rang, and a bit less okay as day turned into night. Yes, I made (less than I should have) money on the long side in ZM during the economic shutdown. This position is something of a gamble versus a terrific run over the past few days from the high-$140s last Wednesday to this morning's pre-opening last sale of $208.80. Will I add today? Probably not. Will I cover prior to the close? If the position is killing my P/L. That's the most honest answer I can give.

Economics (All Times Eastern)

08:55 - Redbook (Weekly): Last -5.5% y/y.

16:30 - API Oil Inventories (Weekly): Last +8.7M.

The Fed (All Times Eastern)

Fed Blackout Period.

Today's Earnings Highlights (Consensus EPS Expectations)

Before the Open: (DKS) (-0.83), (DCI) (0.38)

After the Close: (CRWD) (-0.06), (ZM) (0.10)

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Guilfoyle was long AMZN, PFE equity, short ZM equity.

TAGS: Drug Approvals | Economy | Investing | Markets | Politics | Stocks | Trading | World | U.S. Equity | Coronavirus

More from Stocks

Chevron Is Not Only Greasing the Wheels, It's Turbocharging Them

Jim Collins
Jan 26, 2023 5:07 PM EST

Let's look at why CVX's buyback news is a big deal for investors.

Traders Hold Their Noses and Buy

James "Rev Shark" DePorre
Jan 26, 2023 4:27 PM EST

The dull market got a boost from Tesla, but this is not the kind of action we want to see.

The Long-Term Trend of Booz Allen Hamilton Is Bullish

Bruce Kamich
Jan 26, 2023 12:15 PM EST

If the earnings report is bearish, here's what to know.

As the Bears Battle the Bulls, the Market Action Remains Choppy

James "Rev Shark" DePorre
Jan 26, 2023 11:40 AM EST

GDP, unemployment claims, and durable goods reports were better than expected, creating hope that the Fed will be able to create a soft economic landing.

Charter Communications: The Path of Least Resistance Is Higher

Bruce Kamich
Jan 26, 2023 11:27 AM EST

Here are the key price levels to watch in the days ahead.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 03:06 PM EST BOB LANG

    LEAPS Webinar

    This week, I offered a free webinar session talkin...
  • 02:53 PM EST REAL MONEY

    LIVE EVENT: Chris Versace and "Sarge" Guilfoyle Share Their Stock Market Insights

    This Monday, Jan. 30, at 12 p.m., our very own exp...
  • 04:58 PM EST REAL MONEY

    The Latest AAP Podcast!

    Listen in as AAP Tackles Earnings, the Fed, Recess...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2023 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login